Table 1 Clinical and laboratory characteristics
|  | Arc of calc ≤10° | 10° < Arc of calc ≤60° | p value |
|---|---|---|---|
|  | (n = 36) | (n = 22) |  |
Men, % | 31 (86) | 15 (68) | 0.18 |
Age, y | 65 ± 10 | 72 ± 9 | 0.007 |
Clinical history, n (%) | |||
Myocardial infarction | 10 (28) | 7 (32) | 0.74 |
Previous coronary bypass graft | 1 (3) | 1 (5) | >0.99 |
Hypertension | 25 (69) | 15 (68) | 0.92 |
Dyslipidemia | 23 (64) | 17 (77) | 0.38 |
Current smoker | 6 (17) | 3 (14) | >0.99 |
Diabetes mellitus type 2 | 19 (53) | 10 (45) | 0.59 |
Target plaque location, n (%) | |||
LAD | 22 (61) | 16 (72) | 0.37 |
LCX | 14 (39) | 6 (28) | Â |
Medication, n (%) | |||
Anti-platelet medicine | 36 (100) | 22 (100) | >0.99 |
Statin | 14 (39) | 15 (68) | 0.030 |
Calcium channel blockers | 16 (44) | 8 (36) | 0.54 |
Beta-blockers | 6 (17) | 4 (18) | >0.99 |
Insulin | 4 (11) | 5 (23) | 0.42 |
ARBs or ACEIs | 20 (56) | 13 (59) | 0.79 |
Laboratory parameter | |||
Total cholesterol (mg/dl) | 205 ± 37 | 173 ± 27 | <0.001 |
Triglycerides (mg/dl) | 160 ± 96 | 145 ± 58 | 0.45 |
HDL cholesterol (mg/dl) | 50 ± 9 | 45 ± 11 | 0.12 |
LDL cholesterol (mg/dl) | 120 ± 38 | 98 ± 30 | 0.003 |
Hemoglobin A1c (%) | 6.6 ± 0.9 | 6.6 ± 0.8 | 0.58 |
C-reactive protein (mg/dl) | 0.75 ± 0.51 | 0.15 ± 0.16 | 0.16 |
Blood pressure during catheterization | |||
Systolic pressure (mmHg) | 147 ± 25 | 149 ± 29 | 0.79 |
Diastolic pressure (mmHg) | 74 ± 13 | 74 ± 13 | 0.37 |